- Category
- Micro (2021-22)
- Udyam number
- UDYAM-UP-21-0002999

David Sun Pharmaceuticals Private Limited
About David Sun Pharmaceuticals Private Limited
Data last updated:
David Sun Pharmaceuticals Private Limited is a private limited company based in Howrah, West Bengal, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 25 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24304WB2020PTC239170.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Himanshu Srivastava (Whole-Time Director) and Chandan Kumar Srivastav.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Andul Puillya P.C. Roy Road Kumarpara Unsani Howrah, West Bengal, India – 711302.
As per the financials filed for FY 2022, the company reported a revenue of ₹52,857. For the same year it recorded a net loss of ₹31,784 (net margin -60.1%) and EBITDA of -₹31,784 (EBITDA margin -60.1%).
David Sun Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-21-0002999).
Company details
Recognitions & Rankings of David Sun Pharmaceuticals
Contact details
David Sun Pharmaceuticals Private Limited's registered office is in Howrah, West Bengal.
- Registered AddressAndul Puillya P.C. Roy Road Kumarpara Unsani Howrah, West Bengal, India – 711302
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of David Sun Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of David Sun Pharmaceuticals Private Limited, buy the company report.
Financials of David Sun Pharmaceuticals Private Limited
FY 2022 filings availableDavid Sun Pharmaceuticals Private Limited reported revenue of ₹52,857 for FY 2022.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹31,784 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹31,784 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -60.1% | |
| Net Profit Margin | -60.1% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of David Sun Pharmaceuticals Private Limited, buy the company report.
Board of directors of David Sun Pharmaceuticals Private Limited
David Sun Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandan Kumar Srivastav | Director | 01 Sep 2021 | 5 Years 1 Months | Current |
| Himanshu Srivastava | Whole-Time Director | 25 Aug 2020 | 6 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving David Sun Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for David Sun Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for David Sun Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
David Sun Pharmaceuticals Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Chandan Kumar Srivastav was appointed as Director on 01 Sep 2021.
Frequently asked questions
David Sun Pharmaceuticals is an active private limited company based in Howrah, West Bengal, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 25 August 2020 (6+ years old) and is registered under CIN U24304WB2020PTC239170.
David Sun Pharmaceuticals has 2 current directors:
- Himanshu Srivastava - Whole-Time Director
- Chandan Kumar Srivastav - Director
The latest financial statements of David Sun Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of David Sun Pharmaceuticals is U24304WB2020PTC239170. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
David Sun Pharmaceuticals was incorporated on 25 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kolkata.
Chandan Kumar Srivastav was appointed as Director on 01 Sep 2021. Deepak Kumar Mishra ceased to be Whole-Time Director on 01 Sep 2021. Himanshu Srivastava was appointed as Whole-Time Director on 25 Aug 2020.
Yes, David Sun Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-21-0002999).
The registered office of David Sun Pharmaceuticals is at Andul Puillya P.C. Roy Road Kumarpara Unsani Howrah, West Bengal, India – 711302.
David Sun Pharmaceuticals operates in the food and beverages industry, in the artificial fibres segment.
David Sun Pharmaceuticals can be reached at its registered office: Andul Puillya P.C. Roy Road Kumarpara Unsani Howrah, West Bengal, India – 711302.

